Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Robert Toorawa
Observed names:
R. Toorawa,
Toorawa, Robert
Institution:
Boehringer Ingelheim (United Kingdom)
Observed institutions:
Boehringer Ingelheim (United Kingdom),
Covance (United Kingdom)
OpenAlex ID:
A5068655233
Empagliflozin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Linagliptin and Metformin: A 24-Week Randomized, Double-Blind, Parallel-Group Trial
2016
·
Eirik Søfteland
, Juris J. Meier
, et al.
·
Diabetes Care
·
138
Linagliptin monotherapy in type 2 diabetes patients for whom metformin is inappropriate: an 18‐week randomized, double‐blind, placebo‐controlled phase III trial with a 34‐week active‐controlled extension
2012
·
A. H. Barnett
, S. Patel
, et al.
·
Diabetes Obesity and Metabolism
·
71
Efficacy and safety of linagliptin 2.5 mg twice daily versus 5 mg once daily in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, placebo-controlled trial
2012
·
Stuart A. Ross
, Elizabeth Rafeiro
, et al.
·
Current Medical Research and Opinion
·
51
Use of simulation to compare the performance of minimization with stratified blocked randomization
2008
·
Robert Toorawa
, Michael Adena
, et al.
·
Pharmaceutical Statistics
·
28
Dose-finding evaluation of once-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with asthma: results of a parallel-group study and a crossover study
2015
·
Paul M. O’Byrne
, Tony D’Urzo
, et al.
·
Respiratory Research
·
12
PDF
Linagliptin and pioglitazone combination therapy versus monotherapy with linagliptin or pioglitazone: A randomised, double-blind, parallel-group, multinational clinical trial
2016
·
Michael Albrecht Nauck
, Maximiliano di Domenico
, et al.
·
Diabetes and Vascular Disease Research
·
11
PDF
Randomised, double-blind, placebo-controlled crossover study to investigate different dosing regimens of olodaterol delivered via Respimat® in patients with moderate to severe persistent asthma
2015
·
Kai-Michael Beeh
, Craig LaForce
, et al.
·
Respiratory Research
·
11
PDF
Dose-Finding Study Of 4-Week, Once-Daily Treatment With Olodaterol, A Novel Long-Acting B2-Agonist, In Patients With Asthma
2012
·
Kai-Michael Beeh
, Ekkehard Beck
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
6
Additional file 1: Table S1. of Dose-finding evaluation of once-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with asthma: results of a parallel-group study and a crossover study
2015
·
O’Byrne, Paul
, D’Urzo, Tony
, et al.
·
Figshare
Show more works
View as search
Works count:
11
Citation count:
328
H-index:
7
I10-index:
7
Year
Topic
Type